flumazenil has been researched along with Diseases, Metabolic in 1 studies
Flumazenil: A potent benzodiazepine receptor antagonist. Since it reverses the sedative and other actions of benzodiazepines, it has been suggested as an antidote to benzodiazepine overdoses.
flumazenil : An organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sándor, J | 1 |
| Nagy, A | 1 |
| Földvári, A | 1 |
| Szabó, E | 1 |
| Csenteri, O | 1 |
| Vincze, F | 1 |
| Sipos, V | 1 |
| Kovács, N | 1 |
| Pálinkás, A | 1 |
| Papp, M | 1 |
| Fürjes, G | 1 |
| Ádány, R | 1 |
1 other study available for flumazenil and Diseases, Metabolic
| Article | Year |
|---|---|
Delivery of cardio-metabolic preventive services to Hungarian Roma of different socio-economic strata.
Topics: Adult; Alcoholism; Blood Glucose; Cholesterol; Cross-Sectional Studies; Delivery of Health Care; Edu | 2017 |